Sanofi
Related Filers (50)
- AVENTIS (117)
- REGENERON PHARMACEUTICALS, INC. (70)
- GENZYME CORP (45)
- MEDIVATION, INC. (15)
- Ablynx NV (13)
- ALNYLAM PHARMACEUTICALS, INC. (13)
- MyoKardia Inc (11)
- TOTAL SA (10)
- CHATTEM INC (9)
- BlackRock Inc. (9)
- Synthorx, Inc. (9)
- Bioverativ Inc. (8)
- Translate Bio, Inc. (8)
- IDM PHARMA, INC. (6)
- Regulus Therapeutics Inc. (6)
- Provention Bio, Inc. (6)
- L OREAL S A (5)
- SCYNEXIS INC (5)
- JPMorgan Chase Bank, N.A. - ADR Depositary (5)
- Principia Biopharma Inc. (5)
- Amundi (5)
- INTROGEN THERAPEUTICS INC (4)
- Sanofi-Aventis Amerique du Nord S.N.C. (4)
- Voyager Therapeutics, Inc. (4)
- CAPITAL GROUP INTERNATIONAL INC (3)
- Fulcrum Therapeutics, Inc. (3)
- Icosavax, Inc. (3)
- DODGE & COX (3)
- KUWAIT PETROLEUM CORP (2)
- RHODIA (2)
- TRANSKARYOTIC THERAPIES INC (2)
- GENTA INC DE/ (2)
- AVENTIS INC (2)
- River Acquisition Corp. (2)
- GC Merger Corp. (2)
- KALOBIOS PHARMACEUTICALS INC (2)
- MERRIMACK PHARMACEUTICALS INC (2)
- Unum Therapeutics Inc. (2)
- Inozyme Pharma, Inc. (2)
- ATRIX LABORATORIES INC (1)
- VIROPHARMA INC (1)
- NANOGEN INC (1)
- BMP Sunstone CORP (1)
- GLYCOMIMETICS INC (1)
- IMMUNE DESIGN CORP (1)
- Immune Design Corp. (1)
- The Nasdaq Stock Market LLC (1)
- Revolution Medicines, Inc. (1)
- LAVA Therapeutics NV (1)
- MeiraGTx Holdings plc (1)
- Show More ...
Financials (4)
NT 11-K
Thursday, 6/28/2007
Notice under Rule 12b25 of inability to timely file all or part of a form 11-K for period ending 2006-12-31
NT 11-K
Thursday, 6/28/2007
Notice under Rule 12b25 of inability to timely file all or part of a form 11-K for period ending 2006-12-31
NT 11-K
Friday, 6/30/2006
Notice under Rule 12b25 of inability to timely file all or part of a form 11-K for period ending 2005-12-31
NT 11-K
Friday, 6/30/2006
Notice under Rule 12b25 of inability to timely file all or part of a form 11-K for period ending 2005-12-31
Other (834)
6-K
Thursday, 2/15/2024
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Friday, 2/2/2024
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Thursday, 2/1/2024
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 1/23/2024
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Wednesday, 1/17/2024
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Wednesday, 12/27/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Wednesday, 12/20/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
F-6EF
Monday, 12/18/2023
Auto effective registration statement for American Depositary Receipts representing securities of certain foreign private issuers
6-K
Friday, 12/1/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Friday, 10/27/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Friday, 10/27/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Thursday, 10/26/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Friday, 10/20/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Wednesday, 10/11/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Wednesday, 9/27/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 9/5/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Thursday, 8/10/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Friday, 7/28/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Friday, 7/28/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Friday, 7/28/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Monday, 7/24/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Wednesday, 7/5/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
11-K
Wednesday, 6/28/2023
Annual report of employee stock purchase, savings and similar plans
11-K
Wednesday, 6/28/2023
Annual report of employee stock purchase, savings and similar plans
6-K
Tuesday, 6/20/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Friday, 6/2/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
SD
Tuesday, 5/30/2023
Specialized Disclosure Report filed pursuant to Section 1502 of the Dodd-Frank Wall Street Reform and Consumer Protection Act relating to the use of conflict minerals (Rule 13p-1)
6-K
Tuesday, 5/23/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Thursday, 4/27/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Thursday, 4/27/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Monday, 4/24/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 4/11/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Thursday, 3/23/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 3/14/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Monday, 3/13/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Monday, 3/6/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
20-F
Friday, 2/24/2023
Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)
IRANNOTICE
Friday, 2/24/2023
Notice of disclosure filed in Exchange Act quarterly and annual reports pursuant to Section 219 of the Iran Threat Reduction and Syria Human Rights Act of 2012 and Section 13(r) of the Exchange Act
6-K
Friday, 2/24/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 2/21/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Friday, 2/3/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 1/31/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 1/17/2023
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 12/20/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Friday, 12/2/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Monday, 11/21/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 11/15/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Thursday, 11/10/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Friday, 10/28/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Monday, 10/17/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Monday, 10/3/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Thursday, 9/22/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Monday, 9/12/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Friday, 9/2/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Wednesday, 8/17/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Thursday, 8/11/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Monday, 8/8/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Thursday, 7/28/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Thursday, 7/28/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Wednesday, 7/20/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Wednesday, 7/13/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Friday, 7/8/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Thursday, 6/30/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
11-K
Wednesday, 6/29/2022
Annual report of employee stock purchase, savings and similar plans
11-K
Wednesday, 6/29/2022
Annual report of employee stock purchase, savings and similar plans
6-K
Tuesday, 6/28/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Thursday, 6/16/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Monday, 6/13/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 6/7/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 5/31/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
SD
Wednesday, 5/25/2022
Specialized Disclosure Report filed pursuant to Section 1502 of the Dodd-Frank Wall Street Reform and Consumer Protection Act relating to the use of conflict minerals (Rule 13p-1)
6-K
Wednesday, 5/25/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 5/17/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Monday, 5/16/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Monday, 5/9/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Friday, 4/29/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Thursday, 4/28/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 4/19/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Thursday, 4/7/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Monday, 4/4/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Friday, 4/1/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Thursday, 3/31/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Wednesday, 3/30/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 3/22/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 3/15/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Friday, 3/4/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Thursday, 2/24/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
IRANNOTICE
Wednesday, 2/23/2022
Notice of disclosure filed in Exchange Act quarterly and annual reports pursuant to Section 219 of the Iran Threat Reduction and Syria Human Rights Act of 2012 and Section 13(r) of the Exchange Act
20-F
Wednesday, 2/23/2022
Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)
6-K
Monday, 2/14/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Friday, 2/4/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Friday, 2/4/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Monday, 1/24/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Wednesday, 1/12/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 12/21/2021
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Wednesday, 12/15/2021
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Monday, 12/6/2021
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Monday, 11/22/2021
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 11/9/2021
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Thursday, 10/28/2021
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
Ownership (198)
SC 13G/A
Wednesday, 2/14/2024
Amundi: Major Shareholders
SC 13G/A
Tuesday, 2/13/2024
DODGE & COX: Major Shareholders
SC 13G/A
Tuesday, 2/6/2024
BlackRock Inc.: Major Shareholders
SC 13G
Monday, 11/6/2023
MeiraGTx Holdings plc: Major Shareholders
SC 13G/A
Tuesday, 2/14/2023
DODGE & COX: Major Shareholders
SC 13G/A
Friday, 2/10/2023
Amundi: Major Shareholders
SC 13G/A
Tuesday, 2/7/2023
BlackRock Inc.: Major Shareholders
SC 13G/A
Tuesday, 2/22/2022
Amundi: Major Shareholders
SC 13G
Monday, 2/14/2022
DODGE & COX: Major Shareholders
SC 13G/A
Monday, 2/14/2022
Amundi: Major Shareholders
SC 13G
Tuesday, 2/8/2022
Icosavax, Inc.: Major Shareholders
SC 13G/A
Thursday, 2/3/2022
BlackRock Inc.: Major Shareholders
4
Tuesday, 9/14/2021
Translate Bio, Inc.: Statement of changes in beneficial ownership of securities
SC 13D
Thursday, 8/12/2021
Translate Bio, Inc.: Major Shareholders
3
Thursday, 8/12/2021
Translate Bio, Inc.: Initial statement of beneficial ownership of securities
4
Monday, 8/2/2021
Icosavax, Inc.: Statement of changes in beneficial ownership of securities
3
Wednesday, 7/28/2021
Icosavax, Inc.: Initial statement of beneficial ownership of securities
SC 13G
Wednesday, 3/31/2021
LAVA Therapeutics NV: Major Shareholders
SC 13G
Tuesday, 2/16/2021
Amundi: Major Shareholders
SC 13G
Thursday, 2/11/2021
Revolution Medicines, Inc.: Major Shareholders
SC 13G
Thursday, 2/4/2021
Translate Bio, Inc.: Major Shareholders
SC 13G/A
Monday, 2/1/2021
BlackRock Inc.: Major Shareholders
4
Wednesday, 7/29/2020
Inozyme Pharma, Inc.: Statement of changes in beneficial ownership of securities
3
Thursday, 7/23/2020
Inozyme Pharma, Inc.: Initial statement of beneficial ownership of securities
SC 13D/A
Wednesday, 6/17/2020
REGENERON PHARMACEUTICALS, INC.: Major Shareholders
4
Thursday, 6/11/2020
REGENERON PHARMACEUTICALS, INC.: Statement of changes in beneficial ownership of securities
4
Friday, 5/29/2020
REGENERON PHARMACEUTICALS, INC.: Statement of changes in beneficial ownership of securities
SC 13D/A
Friday, 5/29/2020
REGENERON PHARMACEUTICALS, INC.: Major Shareholders
4
Wednesday, 3/11/2020
REGENERON PHARMACEUTICALS, INC.: Statement of changes in beneficial ownership of securities
SC 13G/A
Monday, 2/10/2020
BlackRock Inc.: Major Shareholders
SC 13G/A
Monday, 2/10/2020
Unum Therapeutics Inc.: Major Shareholders
SC 13G/A
Monday, 2/10/2020
Regulus Therapeutics Inc.: Major Shareholders
SC 13D/A
Monday, 12/9/2019
REGENERON PHARMACEUTICALS, INC.: Major Shareholders
4
Thursday, 9/12/2019
REGENERON PHARMACEUTICALS, INC.: Statement of changes in beneficial ownership of securities
SC 13G
Monday, 7/29/2019
Fulcrum Therapeutics, Inc.: Major Shareholders
4
Tuesday, 7/23/2019
Fulcrum Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
3
Wednesday, 7/17/2019
Fulcrum Therapeutics, Inc.: Initial statement of beneficial ownership of securities
SC 13G/A
Friday, 5/3/2019
ALNYLAM PHARMACEUTICALS, INC.: Major Shareholders
4
Tuesday, 3/12/2019
REGENERON PHARMACEUTICALS INC: Statement of changes in beneficial ownership of securities
SC 13G/A
Friday, 2/15/2019
MyoKardia Inc: Major Shareholders
4
Friday, 2/15/2019
MyoKardia Inc: Statement of changes in beneficial ownership of securities
SC 13G/A
Tuesday, 2/12/2019
SCYNEXIS INC: Major Shareholders
SC 13G/A
Monday, 2/11/2019
BlackRock Inc.: Major Shareholders
SC 13G
Monday, 2/11/2019
Unum Therapeutics Inc.: Major Shareholders
SC 13G/A
Monday, 2/11/2019
Voyager Therapeutics, Inc.: Major Shareholders
SC 13G/A
Monday, 2/11/2019
MyoKardia Inc: Major Shareholders
4
Tuesday, 1/22/2019
ALNYLAM PHARMACEUTICALS, INC.: Statement of changes in beneficial ownership of securities
4
Monday, 9/10/2018
REGENERON PHARMACEUTICALS INC: Statement of changes in beneficial ownership of securities
SC 13D/A
Tuesday, 6/19/2018
Ablynx NV: Major Shareholders
4
Monday, 6/11/2018
REGENERON PHARMACEUTICALS INC: Statement of changes in beneficial ownership of securities
4
Tuesday, 5/29/2018
MyoKardia Inc: Statement of changes in beneficial ownership of securities
SC 13D
Friday, 5/25/2018
Ablynx NV: Major Shareholders
SC 13G/A
Tuesday, 2/13/2018
Regulus Therapeutics Inc.: Major Shareholders
SC 13G/A
Tuesday, 2/13/2018
ALNYLAM PHARMACEUTICALS, INC.: Major Shareholders
SC 13G/A
Tuesday, 2/13/2018
SCYNEXIS INC: Major Shareholders
SC 13G/A
Tuesday, 2/13/2018
MyoKardia Inc: Major Shareholders
SC 13G/A
Thursday, 2/8/2018
BlackRock Inc.: Major Shareholders
SC 13D/A
Tuesday, 1/9/2018
REGENERON PHARMACEUTICALS INC: Major Shareholders
4
Tuesday, 8/29/2017
REGENERON PHARMACEUTICALS INC: Statement of changes in beneficial ownership of securities
4
Friday, 8/25/2017
REGENERON PHARMACEUTICALS INC: Statement of changes in beneficial ownership of securities
4
Wednesday, 8/16/2017
MyoKardia Inc: Statement of changes in beneficial ownership of securities
4
Tuesday, 6/6/2017
REGENERON PHARMACEUTICALS INC: Statement of changes in beneficial ownership of securities
4
Thursday, 6/1/2017
ALNYLAM PHARMACEUTICALS, INC.: Statement of changes in beneficial ownership of securities
SC 13G/A
Thursday, 2/9/2017
MyoKardia Inc: Major Shareholders
SC 13D/A
Tuesday, 1/31/2017
REGENERON PHARMACEUTICALS INC: Major Shareholders
SC 13G/A
Friday, 1/27/2017
BlackRock Inc.: Major Shareholders
4
Friday, 1/13/2017
REGENERON PHARMACEUTICALS INC: Statement of changes in beneficial ownership of securities
4
Wednesday, 10/5/2016
MyoKardia Inc: Statement of changes in beneficial ownership of securities
4
Thursday, 6/16/2016
REGENERON PHARMACEUTICALS INC: Statement of changes in beneficial ownership of securities
4
Thursday, 2/18/2016
REGENERON PHARMACEUTICALS INC: Statement of changes in beneficial ownership of securities
SC 13G
Friday, 2/12/2016
Voyager Therapeutics, Inc.: Major Shareholders
SC 13G/A
Friday, 2/12/2016
ALNYLAM PHARMACEUTICALS, INC.: Major Shareholders
SC 13G
Friday, 2/12/2016
MyoKardia Inc: Major Shareholders
SC 13G
Tuesday, 2/9/2016
BlackRock Inc.: Major Shareholders
4
Wednesday, 2/3/2016
ALNYLAM PHARMACEUTICALS, INC.: Statement of changes in beneficial ownership of securities
4
Thursday, 1/14/2016
REGENERON PHARMACEUTICALS INC: Statement of changes in beneficial ownership of securities
SC 13D/A
Tuesday, 12/29/2015
REGENERON PHARMACEUTICALS INC: Major Shareholders
4
Wednesday, 11/18/2015
Voyager Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
3
Thursday, 11/12/2015
Voyager Therapeutics, Inc.: Initial statement of beneficial ownership of securities
4
Thursday, 11/5/2015
MyoKardia Inc: Statement of changes in beneficial ownership of securities
3
Wednesday, 10/28/2015
MyoKardia Inc: Initial statement of beneficial ownership of securities
4
Thursday, 10/8/2015
REGENERON PHARMACEUTICALS INC: Statement of changes in beneficial ownership of securities
4
Thursday, 10/8/2015
REGENERON PHARMACEUTICALS INC: Statement of changes in beneficial ownership of securities
4
Friday, 9/25/2015
REGENERON PHARMACEUTICALS INC: Statement of changes in beneficial ownership of securities
4
Wednesday, 7/29/2015
REGENERON PHARMACEUTICALS INC: Statement of changes in beneficial ownership of securities
SC 13G/A
Friday, 2/13/2015
MERRIMACK PHARMACEUTICALS INC: Major Shareholders
SC 13G/A
Friday, 2/13/2015
SCYNEXIS INC: Major Shareholders
4/A
Monday, 2/2/2015
ALNYLAM PHARMACEUTICALS, INC.: Statement of changes in beneficial ownership of securities
4
Monday, 2/2/2015
ALNYLAM PHARMACEUTICALS, INC.: Statement of changes in beneficial ownership of securities
SC 13G/A
Monday, 2/2/2015
ALNYLAM PHARMACEUTICALS, INC.: Major Shareholders
4
Wednesday, 1/28/2015
ALNYLAM PHARMACEUTICALS, INC.: Statement of changes in beneficial ownership of securities
4
Monday, 12/29/2014
REGENERON PHARMACEUTICALS INC: Statement of changes in beneficial ownership of securities
4
Monday, 10/20/2014
REGENERON PHARMACEUTICALS INC: Statement of changes in beneficial ownership of securities
SC 13D/A
Friday, 10/17/2014
REGENERON PHARMACEUTICALS INC: Major Shareholders
4
Friday, 10/17/2014
REGENERON PHARMACEUTICALS INC: Statement of changes in beneficial ownership of securities
4
Thursday, 9/18/2014
REGENERON PHARMACEUTICALS INC: Statement of changes in beneficial ownership of securities
4
Tuesday, 9/16/2014
REGENERON PHARMACEUTICALS INC: Statement of changes in beneficial ownership of securities
SC 13G
Friday, 8/1/2014
Immune Design Corp.: Major Shareholders
SC 13D/A
Thursday, 7/31/2014
REGENERON PHARMACEUTICALS INC: Major Shareholders
SC 13G
Thursday, 7/31/2014
IMMUNE DESIGN CORP: Major Shareholders
Prospectus (250)
SC TO-T/A
Thursday, 4/27/2023
Third party tender offer statement
SC TO-T/A
Wednesday, 4/26/2023
Third party tender offer statement
SC TO-T/A
Monday, 4/10/2023
Third party tender offer statement
S-8
Thursday, 3/30/2023
Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
SC TO-T
Friday, 3/24/2023
Third party tender offer statement
SC TO-C
Friday, 3/17/2023
Written communication relating to an issuer or third party tender offer
S-8 POS
Monday, 3/13/2023
Post-effective amendment to a S-8 registration statement
SC TO-C
Monday, 3/13/2023
Written communication relating to an issuer or third party tender offer
S-8
Wednesday, 5/18/2022
Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
S-8 POS
Tuesday, 5/17/2022
Post-effective amendment to a S-8 registration statement
SC TO-T/A
Tuesday, 9/14/2021
Third party tender offer statement
SC TO-T/A
Friday, 8/27/2021
Third party tender offer statement
SC TO-T
Monday, 8/16/2021
Third party tender offer statement
SC TO-C
Tuesday, 8/3/2021
Written communication relating to an issuer or third party tender offer
S-8
Monday, 5/17/2021
Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
S-8 POS
Friday, 4/23/2021
Post-effective amendment to a S-8 registration statement
SC TO-T/A
Monday, 9/28/2020
Third party tender offer statement
SC TO-T/A
Tuesday, 9/22/2020
Third party tender offer statement
SC TO-T/A
Monday, 9/14/2020
Third party tender offer statement
SC TO-T
Friday, 8/28/2020
Third party tender offer statement
SC TO-C
Tuesday, 8/18/2020
Written communication relating to an issuer or third party tender offer
FWP
Tuesday, 5/26/2020
Filing under Securities Act Rules 163/433 of free writing prospectuses
S-8
Tuesday, 5/26/2020
Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
S-8 POS
Wednesday, 5/13/2020
Post-effective amendment to a S-8 registration statement
SC TO-T/A
Thursday, 1/23/2020
Third party tender offer statement
SC TO-T/A
Tuesday, 1/21/2020
Third party tender offer statement
SC TO-T/A
Thursday, 1/9/2020
Third party tender offer statement
SC TO-T/A
Tuesday, 1/7/2020
Third party tender offer statement
SC TO-T
Monday, 12/23/2019
Third party tender offer statement
SC TO-C
Wednesday, 12/11/2019
Written communication relating to an issuer or third party tender offer
SC TO-C
Tuesday, 12/10/2019
Written communication relating to an issuer or third party tender offer
SC TO-C
Monday, 12/9/2019
Written communication relating to an issuer or third party tender offer
SC TO-T/A
Tuesday, 6/19/2018
Third party tender offer statement
424B5
Thursday, 6/14/2018
Prospectus filed pursuant to Rule 424(b)(5)
FWP
Wednesday, 6/13/2018
Filing under Securities Act Rules 163/433 of free writing prospectuses
FWP
Wednesday, 6/13/2018
Filing under Securities Act Rules 163/433 of free writing prospectuses
SC TO-T/A
Tuesday, 6/12/2018
Third party tender offer statement
424B5
Tuesday, 6/12/2018
Prospectus filed pursuant to Rule 424(b)(5)
S-8
Friday, 6/8/2018
Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
SC TO-T/A
Friday, 5/18/2018
Third party tender offer statement
S-8 POS
Tuesday, 5/15/2018
Post-effective amendment to a S-8 registration statement
SC TO-T/A
Monday, 5/14/2018
Third party tender offer statement
SC TO-T/A
Monday, 5/7/2018
Third party tender offer statement
SC TO-T
Wednesday, 4/4/2018
Third party tender offer statement
SC TO-C
Thursday, 3/29/2018
Written communication relating to an issuer or third party tender offer
SC TO-T/A
Thursday, 3/8/2018
Third party tender offer statement
SC TO-C
Thursday, 3/1/2018
Written communication relating to an issuer or third party tender offer
SC TO-T/A
Friday, 2/23/2018
Third party tender offer statement
SC TO-T/A
Tuesday, 2/20/2018
Third party tender offer statement
SC TO-C
Tuesday, 2/20/2018
Written communication relating to an issuer or third party tender offer
SC TO-T/A
Friday, 2/9/2018
Third party tender offer statement
SC TO-T/A
Thursday, 2/8/2018
Third party tender offer statement
SC TO-T
Wednesday, 2/7/2018
Third party tender offer statement
SC TO-C
Tuesday, 1/30/2018
Written communication relating to an issuer or third party tender offer
SC TO-C
Monday, 1/29/2018
Written communication relating to an issuer or third party tender offer
SC TO-C
Tuesday, 1/23/2018
Written communication relating to an issuer or third party tender offer
SC TO-C
Monday, 1/22/2018
Written communication relating to an issuer or third party tender offer
S-8
Friday, 5/19/2017
Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
S-8 POS
Tuesday, 5/16/2017
Post-effective amendment to a S-8 registration statement
S-8
Tuesday, 5/10/2016
Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
S-8 POS
Monday, 4/25/2016
Post-effective amendment to a S-8 registration statement
424B3
Monday, 3/24/2014
Prospectus filed pursuant to Rule 424(b)(3)
S-8
Wednesday, 11/6/2013
Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
424B5
Friday, 4/5/2013
Prospectus filed pursuant to Rule 424(b)(5)
424B5
Wednesday, 4/3/2013
Prospectus filed pursuant to Rule 424(b)(5)
FWP
Wednesday, 4/3/2013
Filing under Securities Act Rules 163/433 of free writing prospectuses
424B5
Wednesday, 9/28/2011
Prospectus filed pursuant to Rule 424(b)(5)
424B5
Tuesday, 9/27/2011
Prospectus filed pursuant to Rule 424(b)(5)
FWP
Tuesday, 9/27/2011
Filing under Securities Act Rules 163/433 of free writing prospectuses
424B3
Monday, 5/9/2011
Prospectus filed pursuant to Rule 424(b)(3)
425
Friday, 4/8/2011
Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
SC TO-T/A
Friday, 4/8/2011
Third party tender offer statement
425
Monday, 4/4/2011
Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
SC TO-T/A
Monday, 4/4/2011
Third party tender offer statement
SC TO-T/A
Thursday, 3/31/2011
Third party tender offer statement
424B3
Wednesday, 3/30/2011
Prospectus filed pursuant to Rule 424(b)(3)
425
Tuesday, 3/29/2011
Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
SC TO-T/A
Tuesday, 3/29/2011
Third party tender offer statement
SC TO-T/A
Thursday, 3/24/2011
Third party tender offer statement
424B5
Thursday, 3/24/2011
Prospectus filed pursuant to Rule 424(b)(5)
425
Wednesday, 3/23/2011
Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
SC TO-T/A
Wednesday, 3/23/2011
Third party tender offer statement
FWP
Wednesday, 3/23/2011
Filing under Securities Act Rules 163/433 of free writing prospectuses
FWP
Wednesday, 3/23/2011
Filing under Securities Act Rules 163/433 of free writing prospectuses
424B5
Tuesday, 3/22/2011
Prospectus filed pursuant to Rule 424(b)(5)
SC TO-T/A
Friday, 3/18/2011
Third party tender offer statement
425
Monday, 3/7/2011
Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
SC TO-T/A
Monday, 3/7/2011
Third party tender offer statement
425
Friday, 2/18/2011
Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
SC TO-T/A
Friday, 2/18/2011
Third party tender offer statement
425
Thursday, 2/17/2011
Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
SC TO-T/A
Thursday, 2/17/2011
Third party tender offer statement
425
Wednesday, 2/16/2011
Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
SC TO-T/A
Wednesday, 2/16/2011
Third party tender offer statement
425
Wednesday, 2/16/2011
Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
425
Wednesday, 2/16/2011
Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
SC TO-T/A
Wednesday, 2/16/2011
Third party tender offer statement
SC TO-T/A
Wednesday, 2/9/2011
Third party tender offer statement
SC TO-T/A
Monday, 1/31/2011
Third party tender offer statement
SC TO-T/A
Monday, 1/24/2011
Third party tender offer statement
Proxies (15)
DFAN14A
Tuesday, 7/5/2016
Definitive additional proxy soliciting materials filed by non-management including Rule 14(a)(12) material
DFAN14A
Tuesday, 6/14/2016
Definitive additional proxy soliciting materials filed by non-management including Rule 14(a)(12) material
DEFC14A
Monday, 6/13/2016
Definitive proxy statement in connection with contested solicitations
DFAN14A
Monday, 6/13/2016
Definitive additional proxy soliciting materials filed by non-management including Rule 14(a)(12) material
PRRN14A
Thursday, 6/9/2016
Revised preliminary proxy statement filed by non-management
DFAN14A
Wednesday, 6/8/2016
Definitive additional proxy soliciting materials filed by non-management including Rule 14(a)(12) material
DFAN14A
Wednesday, 6/8/2016
Definitive additional proxy soliciting materials filed by non-management including Rule 14(a)(12) material
PRRN14A
Tuesday, 6/7/2016
Revised preliminary proxy statement filed by non-management
DFAN14A
Wednesday, 6/1/2016
Definitive additional proxy soliciting materials filed by non-management including Rule 14(a)(12) material
PREC14A
Wednesday, 5/25/2016
Preliminary proxy statement in connection with contested solicitations
DFAN14A
Wednesday, 5/25/2016
Definitive additional proxy soliciting materials filed by non-management including Rule 14(a)(12) material
DFAN14A
Thursday, 5/12/2016
Definitive additional proxy soliciting materials filed by non-management including Rule 14(a)(12) material
DFAN14A
Thursday, 5/5/2016
Definitive additional proxy soliciting materials filed by non-management including Rule 14(a)(12) material
DFAN14A
Friday, 4/29/2016
Definitive additional proxy soliciting materials filed by non-management including Rule 14(a)(12) material
DFAN14A
Thursday, 4/28/2016
Definitive additional proxy soliciting materials filed by non-management including Rule 14(a)(12) material